

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 6.13002206 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.98798568 |
| 3 | rhodopsin mediated signaling pathway (GO:0016056) | 5.93432596 |
| 4 | retinal cone cell development (GO:0046549) | 5.88310773 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.74094260 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.56313776 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.56313776 |
| 8 | nuclear pore complex assembly (GO:0051292) | 5.26759895 |
| 9 | nuclear pore organization (GO:0006999) | 5.03898344 |
| 10 | photoreceptor cell development (GO:0042461) | 4.94756418 |
| 11 | eye photoreceptor cell development (GO:0042462) | 4.93030220 |
| 12 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 4.68356677 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.53872376 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.51092132 |
| 15 | negative T cell selection (GO:0043383) | 4.49263643 |
| 16 | photoreceptor cell maintenance (GO:0045494) | 4.45260399 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.43370075 |
| 18 | cellular response to ethanol (GO:0071361) | 4.33621382 |
| 19 | regulation of gene silencing by RNA (GO:0060966) | 4.31924157 |
| 20 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.31924157 |
| 21 | regulation of gene silencing by miRNA (GO:0060964) | 4.31924157 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.21652558 |
| 23 | pore complex assembly (GO:0046931) | 4.18439316 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 4.17595158 |
| 25 | GMP metabolic process (GO:0046037) | 3.90612553 |
| 26 | positive T cell selection (GO:0043368) | 3.85622848 |
| 27 | response to interleukin-15 (GO:0070672) | 3.82926118 |
| 28 | negative regulation of histone methylation (GO:0031061) | 3.81595737 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.76955271 |
| 30 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.75105441 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.72371358 |
| 32 | retinal rod cell development (GO:0046548) | 3.71753421 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 3.70728517 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.67343508 |
| 35 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.60757050 |
| 36 | detection of light stimulus involved in visual perception (GO:0050908) | 3.60757050 |
| 37 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.59520464 |
| 38 | mitotic sister chromatid cohesion (GO:0007064) | 3.57135795 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.53457878 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.52825971 |
| 41 | T cell selection (GO:0045058) | 3.51014500 |
| 42 | T cell migration (GO:0072678) | 3.50617705 |
| 43 | regulation of centriole replication (GO:0046599) | 3.47872811 |
| 44 | regulation of gene silencing (GO:0060968) | 3.43291099 |
| 45 | regulation of helicase activity (GO:0051095) | 3.42232248 |
| 46 | regulation of histone H3-K9 methylation (GO:0051570) | 3.41486037 |
| 47 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.40496436 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39531045 |
| 49 | histone H2A monoubiquitination (GO:0035518) | 3.38276360 |
| 50 | detection of other organism (GO:0098543) | 3.34214190 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.34159070 |
| 52 | regulation of DNA endoreduplication (GO:0032875) | 3.32638782 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.31273912 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29433108 |
| 55 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.29114467 |
| 56 | histone H3-K4 trimethylation (GO:0080182) | 3.28616533 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.26334822 |
| 58 | cellular response to light stimulus (GO:0071482) | 3.24014688 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.23791833 |
| 60 | T-helper cell differentiation (GO:0042093) | 3.23336309 |
| 61 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.23336309 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23238397 |
| 63 | cellular extravasation (GO:0045123) | 3.22942784 |
| 64 | detection of bacterium (GO:0016045) | 3.21442519 |
| 65 | thymic T cell selection (GO:0045061) | 3.20277458 |
| 66 | response to muramyl dipeptide (GO:0032495) | 3.19261587 |
| 67 | histone H3-K36 demethylation (GO:0070544) | 3.16588371 |
| 68 | regulation of histone H3-K27 methylation (GO:0061085) | 3.16285558 |
| 69 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.16095320 |
| 70 | histone H3-K4 methylation (GO:0051568) | 3.15354778 |
| 71 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.15108138 |
| 72 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.15108138 |
| 73 | histone H4-K12 acetylation (GO:0043983) | 3.14591475 |
| 74 | negative regulation of B cell proliferation (GO:0030889) | 3.14443634 |
| 75 | pre-miRNA processing (GO:0031054) | 3.12936866 |
| 76 | regulation of chromatin silencing (GO:0031935) | 3.12382055 |
| 77 | interferon-gamma production (GO:0032609) | 3.12309442 |
| 78 | phototransduction, visible light (GO:0007603) | 3.12008594 |
| 79 | tolerance induction (GO:0002507) | 3.11386461 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09972763 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09972763 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 3.09972763 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09972763 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 3.09972763 |
| 85 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09972763 |
| 86 | neutrophil activation involved in immune response (GO:0002283) | 3.08229414 |
| 87 | leukocyte aggregation (GO:0070486) | 3.03717076 |
| 88 | phototransduction (GO:0007602) | 3.02685272 |
| 89 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.02127017 |
| 90 | negative regulation of gene silencing (GO:0060969) | 3.01587450 |
| 91 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.01381237 |
| 92 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.01103951 |
| 93 | protein-chromophore linkage (GO:0018298) | 3.00747342 |
| 94 | mitotic nuclear envelope disassembly (GO:0007077) | 3.00557546 |
| 95 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00119434 |
| 96 | detection of visible light (GO:0009584) | 2.98672237 |
| 97 | B cell homeostasis (GO:0001782) | 2.97840764 |
| 98 | mast cell activation (GO:0045576) | 2.94833261 |
| 99 | protein localization to kinetochore (GO:0034501) | 2.94059989 |
| 100 | histone H4-K5 acetylation (GO:0043981) | 2.93852376 |
| 101 | histone H4-K8 acetylation (GO:0043982) | 2.93852376 |
| 102 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93846368 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93846368 |
| 104 | determination of adult lifespan (GO:0008340) | 2.93646077 |
| 105 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93143276 |
| 106 | regulation of protein polyubiquitination (GO:1902914) | 2.92653601 |
| 107 | detection of external biotic stimulus (GO:0098581) | 2.92577376 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91148867 |
| 109 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.89011019 |
| 110 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.88533372 |
| 111 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.88533372 |
| 112 | T cell differentiation involved in immune response (GO:0002292) | 2.88533372 |
| 113 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.87445566 |
| 114 | regulation of sister chromatid cohesion (GO:0007063) | 2.87241410 |
| 115 | alpha-beta T cell differentiation (GO:0046632) | 2.86068108 |
| 116 | detection of light stimulus (GO:0009583) | 2.85953843 |
| 117 | immunoglobulin mediated immune response (GO:0016064) | 2.84589575 |
| 118 | regulation of tolerance induction (GO:0002643) | 2.84460819 |
| 119 | regulation of histone methylation (GO:0031060) | 2.84287940 |
| 120 | visual perception (GO:0007601) | 2.82343256 |
| 121 | detection of molecule of bacterial origin (GO:0032490) | 2.82145998 |
| 122 | sensory perception of light stimulus (GO:0050953) | 2.81725418 |
| 123 | alpha-beta T cell activation (GO:0046631) | 2.81718333 |
| 124 | nuclear envelope disassembly (GO:0051081) | 2.81228880 |
| 125 | membrane disassembly (GO:0030397) | 2.81228880 |
| 126 | hepatocyte apoptotic process (GO:0097284) | 2.80881776 |
| 127 | myeloid cell activation involved in immune response (GO:0002275) | 2.79385892 |
| 128 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.78888364 |
| 129 | regulation of RNA export from nucleus (GO:0046831) | 2.78448349 |
| 130 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.78018453 |
| 131 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.77900905 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.76837987 |
| 133 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76760088 |
| 134 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76432963 |
| 135 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.75893519 |
| 136 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.74872086 |
| 137 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.74336762 |
| 138 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.74336762 |
| 139 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.74336762 |
| 140 | T cell receptor signaling pathway (GO:0050852) | 2.73788569 |
| 141 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.73465360 |
| 142 | definitive hemopoiesis (GO:0060216) | 2.72924600 |
| 143 | B cell proliferation (GO:0042100) | 2.72915662 |
| 144 | DNA geometric change (GO:0032392) | 2.72608581 |
| 145 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.72546228 |
| 146 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.72546228 |
| 147 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.72546228 |
| 148 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.71387322 |
| 149 | negative regulation of interleukin-12 production (GO:0032695) | 2.71263557 |
| 150 | DNA duplex unwinding (GO:0032508) | 2.70750851 |
| 151 | replicative senescence (GO:0090399) | 2.70441029 |
| 152 | * histone H3-K9 demethylation (GO:0033169) | 2.69779783 |
| 153 | response to peptidoglycan (GO:0032494) | 2.69599913 |
| 154 | positive regulation of tolerance induction (GO:0002645) | 2.69579696 |
| 155 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.69420080 |
| 156 | mature B cell differentiation (GO:0002335) | 2.69374243 |
| 157 | activated T cell proliferation (GO:0050798) | 2.69347418 |
| 158 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68360907 |
| 159 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.65827479 |
| 160 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.65827479 |
| 161 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.63638476 |
| 162 | regulation of B cell proliferation (GO:0030888) | 2.63252677 |
| 163 | * histone demethylation (GO:0016577) | 2.62274717 |
| 164 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.62017398 |
| 165 | phospholipid efflux (GO:0033700) | 2.61980508 |
| 166 | regulation of germinal center formation (GO:0002634) | 2.61641148 |
| 167 | * histone lysine demethylation (GO:0070076) | 2.61619181 |
| 168 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.61478303 |
| 169 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61400271 |
| 170 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.60210173 |
| 171 | mRNA transcription (GO:0009299) | 2.60157346 |
| 172 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.58080911 |
| 173 | stress granule assembly (GO:0034063) | 2.57010944 |
| 174 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.56098818 |
| 175 | negative regulation of adaptive immune response (GO:0002820) | 2.55132304 |
| 176 | histone H4-K16 acetylation (GO:0043984) | 2.54988472 |
| 177 | microglial cell activation (GO:0001774) | 2.54480702 |
| 178 | regulation of mast cell degranulation (GO:0043304) | 2.54382855 |
| 179 | regulation of granulocyte differentiation (GO:0030852) | 2.54360413 |
| 180 | chromatin assembly (GO:0031497) | 2.54056520 |
| 181 | regulation of centrosome duplication (GO:0010824) | 2.54006492 |
| 182 | regulation of hypersensitivity (GO:0002883) | 2.53809323 |
| 183 | metaphase plate congression (GO:0051310) | 2.52468652 |
| 184 | mismatch repair (GO:0006298) | 2.52173966 |
| 185 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.51888325 |
| 186 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.51400173 |
| 187 | cellular response to radiation (GO:0071478) | 2.51334586 |
| 188 | tRNA methylation (GO:0030488) | 2.50233800 |
| 189 | regulation of spindle organization (GO:0090224) | 2.49928078 |
| 190 | regulation of centrosome cycle (GO:0046605) | 2.49808089 |
| 191 | mitotic metaphase plate congression (GO:0007080) | 2.49127337 |
| 192 | response to UV-C (GO:0010225) | 2.47473480 |
| 193 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.47248875 |
| 194 | embryonic placenta development (GO:0001892) | 2.47048339 |
| 195 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.46038299 |
| 196 | protein localization to chromosome, centromeric region (GO:0071459) | 2.45457319 |
| 197 | positive regulation of histone methylation (GO:0031062) | 2.44782086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.64375258 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71703090 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 4.60066612 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.70952604 |
| 5 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.51644726 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.24175184 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22310077 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.09567117 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.01240760 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.87108535 |
| 11 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.80451540 |
| 12 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.80451540 |
| 13 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.80451540 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76834196 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66819213 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.63350821 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57174599 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57004354 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42914846 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24338862 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23008580 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.22003119 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21074940 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20222402 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19732614 |
| 26 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.13798509 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.13452494 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.09302384 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07551026 |
| 30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.99123731 |
| 31 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.96384529 |
| 32 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.94239066 |
| 33 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90403204 |
| 34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.87515901 |
| 35 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.87140343 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86097042 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77413863 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75630408 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75057973 |
| 40 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.72968705 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.68243675 |
| 42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.62887407 |
| 43 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.61348832 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.60908924 |
| 45 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.59311550 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.59142313 |
| 47 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.57437959 |
| 48 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.57160200 |
| 49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56910664 |
| 50 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.56846805 |
| 51 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.56644918 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.54305843 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53928676 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52979381 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.51047089 |
| 56 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.48941141 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48041759 |
| 58 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47587440 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47508347 |
| 60 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.43456866 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42517667 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42359347 |
| 63 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.41786238 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39823258 |
| 65 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38240873 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.35075986 |
| 67 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34600781 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33666453 |
| 69 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33387498 |
| 70 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32146844 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31972161 |
| 72 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.30203529 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29920081 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29790466 |
| 75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29763023 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28804463 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28155870 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27717677 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27218290 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26750247 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26429540 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25866691 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25817949 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25402866 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24106339 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22766321 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22196197 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20963248 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20323644 |
| 90 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20293609 |
| 91 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.19727353 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18898768 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17929387 |
| 94 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.17051588 |
| 95 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.16123639 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16022180 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15613250 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14243886 |
| 99 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13849643 |
| 100 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13788491 |
| 101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12353221 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11298480 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11294687 |
| 104 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.10338633 |
| 105 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.10026243 |
| 106 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09662041 |
| 107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09115955 |
| 108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08969574 |
| 109 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.08844311 |
| 110 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.08262983 |
| 111 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07243580 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06834208 |
| 113 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.06568879 |
| 114 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.06088465 |
| 115 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05696785 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05437060 |
| 117 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04484413 |
| 118 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03622013 |
| 119 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03109151 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03099944 |
| 121 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.01514869 |
| 122 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00590864 |
| 123 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.00489195 |
| 124 | MYC_22102868_ChIP-Seq_BL_Human | 1.00343438 |
| 125 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00326946 |
| 126 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00220060 |
| 127 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00104692 |
| 128 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.99645726 |
| 129 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.99064531 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98869834 |
| 131 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98200546 |
| 132 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97249334 |
| 133 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95892762 |
| 134 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.95476683 |
| 135 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.95399159 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95184794 |
| 137 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94619720 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94101260 |
| 139 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.93044940 |
| 140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92738275 |
| 141 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.92683790 |
| 142 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92058001 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91584916 |
| 144 | MAF_26560356_Chip-Seq_TH2_Human | 0.89927810 |
| 145 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89880042 |
| 146 | EWS_26573619_Chip-Seq_HEK293_Human | 0.89771264 |
| 147 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.89518540 |
| 148 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88498753 |
| 149 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87585301 |
| 150 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87197326 |
| 151 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86915442 |
| 152 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86444476 |
| 153 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84542441 |
| 154 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84061867 |
| 155 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83882904 |
| 156 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83786225 |
| 157 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82828529 |
| 158 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82817225 |
| 159 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81974264 |
| 160 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.81694660 |
| 161 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79744670 |
| 162 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.79578199 |
| 163 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79545282 |
| 164 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78754776 |
| 165 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78288796 |
| 166 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.77990080 |
| 167 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.77265654 |
| 168 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.76707159 |
| 169 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.76344133 |
| 170 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.76194209 |
| 171 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.75904899 |
| 172 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75368241 |
| 173 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74043806 |
| 174 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74000039 |
| 175 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.73733861 |
| 176 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73622139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 4.64515744 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 4.42521496 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 4.25253105 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.93939744 |
| 5 | MP0005253_abnormal_eye_physiology | 3.88098973 |
| 6 | MP0003011_delayed_dark_adaptation | 3.12347933 |
| 7 | MP0003724_increased_susceptibility_to | 3.09511937 |
| 8 | MP0008057_abnormal_DNA_replication | 3.01989887 |
| 9 | MP0001800_abnormal_humoral_immune | 2.97119652 |
| 10 | MP0000685_abnormal_immune_system | 2.85902848 |
| 11 | MP0003436_decreased_susceptibility_to | 2.79448800 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.72460689 |
| 13 | MP0008058_abnormal_DNA_repair | 2.70216143 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.67185493 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.65572020 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.60053232 |
| 17 | MP0005387_immune_system_phenotype | 2.58585369 |
| 18 | MP0001790_abnormal_immune_system | 2.58585369 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.55344098 |
| 20 | MP0002009_preneoplasia | 2.49259467 |
| 21 | MP0003303_peritoneal_inflammation | 2.45206233 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 2.40165138 |
| 23 | MP0002723_abnormal_immune_serum | 2.39297147 |
| 24 | MP0006292_abnormal_olfactory_placode | 2.35773297 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.31938080 |
| 26 | MP0003077_abnormal_cell_cycle | 2.30642275 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.26921588 |
| 28 | MP0001819_abnormal_immune_cell | 2.24174690 |
| 29 | MP0002419_abnormal_innate_immunity | 2.22315406 |
| 30 | MP0005391_vision/eye_phenotype | 2.21146108 |
| 31 | MP0003787_abnormal_imprinting | 2.21065961 |
| 32 | MP0009785_altered_susceptibility_to | 2.14806504 |
| 33 | MP0005025_abnormal_response_to | 2.13618250 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 2.02446385 |
| 35 | MP0005076_abnormal_cell_differentiation | 2.02444457 |
| 36 | MP0004957_abnormal_blastocyst_morpholog | 2.01422261 |
| 37 | MP0003693_abnormal_embryo_hatching | 1.99296859 |
| 38 | MP0001324_abnormal_eye_pigmentation | 1.91651319 |
| 39 | MP0002405_respiratory_system_inflammati | 1.86159213 |
| 40 | MP0000716_abnormal_immune_system | 1.84671215 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.84538798 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.84231878 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.83456091 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.83151194 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.81975406 |
| 46 | MP0006082_CNS_inflammation | 1.80059864 |
| 47 | MP0005195_abnormal_posterior_eye | 1.79658607 |
| 48 | MP0000516_abnormal_urinary_system | 1.78550808 |
| 49 | MP0005367_renal/urinary_system_phenotyp | 1.78550808 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.75249249 |
| 51 | MP0010307_abnormal_tumor_latency | 1.74950883 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.74373763 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.74327186 |
| 54 | MP0004947_skin_inflammation | 1.68550759 |
| 55 | MP0002722_abnormal_immune_system | 1.66896181 |
| 56 | MP0002653_abnormal_ependyma_morphology | 1.66883481 |
| 57 | MP0000350_abnormal_cell_proliferation | 1.60704153 |
| 58 | MP0003890_abnormal_embryonic-extraembry | 1.54203257 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.53587943 |
| 60 | MP0004381_abnormal_hair_follicle | 1.53562899 |
| 61 | MP0008260_abnormal_autophagy | 1.51749036 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.50068101 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.47662315 |
| 64 | MP0002429_abnormal_blood_cell | 1.44997087 |
| 65 | MP0003121_genomic_imprinting | 1.43032474 |
| 66 | MP0003866_abnormal_defecation | 1.41529029 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.31206624 |
| 68 | MP0001730_embryonic_growth_arrest | 1.28820383 |
| 69 | MP0000371_diluted_coat_color | 1.26853234 |
| 70 | MP0003828_pulmonary_edema | 1.26726577 |
| 71 | MP0000604_amyloidosis | 1.26712517 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.23351064 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.22753107 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.22753107 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 1.21350660 |
| 76 | MP0001873_stomach_inflammation | 1.20877595 |
| 77 | MP0008877_abnormal_DNA_methylation | 1.19192921 |
| 78 | MP0002084_abnormal_developmental_patter | 1.17904954 |
| 79 | MP0004885_abnormal_endolymph | 1.17269843 |
| 80 | MP0001851_eye_inflammation | 1.16820049 |
| 81 | MP0001853_heart_inflammation | 1.15604245 |
| 82 | MP0004197_abnormal_fetal_growth/weight/ | 1.13604526 |
| 83 | MP0001697_abnormal_embryo_size | 1.13431683 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.13349086 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.12463243 |
| 86 | MP0003690_abnormal_glial_cell | 1.11711276 |
| 87 | MP0001672_abnormal_embryogenesis/_devel | 1.11517596 |
| 88 | MP0005380_embryogenesis_phenotype | 1.11517596 |
| 89 | MP0003123_paternal_imprinting | 1.11175302 |
| 90 | MP0001293_anophthalmia | 1.10555344 |
| 91 | MP0002166_altered_tumor_susceptibility | 1.08527850 |
| 92 | MP0005671_abnormal_response_to | 1.07631214 |
| 93 | MP0001286_abnormal_eye_development | 1.07368253 |
| 94 | MP0003136_yellow_coat_color | 1.07236217 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 1.06999152 |
| 96 | MP0002638_abnormal_pupillary_reflex | 1.05547282 |
| 97 | MP0002085_abnormal_embryonic_tissue | 1.03788666 |
| 98 | MP0008469_abnormal_protein_level | 1.03572452 |
| 99 | MP0009703_decreased_birth_body | 0.99897120 |
| 100 | MP0002006_tumorigenesis | 0.99611358 |
| 101 | MP0002088_abnormal_embryonic_growth/wei | 0.99108476 |
| 102 | MP0003984_embryonic_growth_retardation | 0.98228413 |
| 103 | MP0002090_abnormal_vision | 0.97038841 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.95520174 |
| 105 | MP0009764_decreased_sensitivity_to | 0.93672424 |
| 106 | MP0009840_abnormal_foam_cell | 0.93110027 |
| 107 | MP0003252_abnormal_bile_duct | 0.92868998 |
| 108 | MP0002080_prenatal_lethality | 0.92466524 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.92131287 |
| 110 | MP0005365_abnormal_bile_salt | 0.91016683 |
| 111 | MP0003091_abnormal_cell_migration | 0.90338102 |
| 112 | MP0002075_abnormal_coat/hair_pigmentati | 0.89610678 |
| 113 | MP0001661_extended_life_span | 0.87055438 |
| 114 | MP0001915_intracranial_hemorrhage | 0.86706545 |
| 115 | MP0003045_fibrosis | 0.86365478 |
| 116 | MP0002229_neurodegeneration | 0.85571494 |
| 117 | MP0003941_abnormal_skin_development | 0.85526691 |
| 118 | MP0002933_joint_inflammation | 0.85024223 |
| 119 | MP0003786_premature_aging | 0.84569805 |
| 120 | MP0004883_abnormal_blood_vessel | 0.82529942 |
| 121 | MP0003763_abnormal_thymus_physiology | 0.82332889 |
| 122 | MP0000703_abnormal_thymus_morphology | 0.81834884 |
| 123 | MP0002095_abnormal_skin_pigmentation | 0.80438605 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.79767857 |
| 125 | MP0006054_spinal_hemorrhage | 0.78781904 |
| 126 | MP0004484_altered_response_of | 0.78211054 |
| 127 | MP0001186_pigmentation_phenotype | 0.76728059 |
| 128 | MP0010234_abnormal_vibrissa_follicle | 0.76167326 |
| 129 | MP0002925_abnormal_cardiovascular_devel | 0.75321375 |
| 130 | MP0000313_abnormal_cell_death | 0.73256795 |
| 131 | MP0009763_increased_sensitivity_to | 0.73207297 |
| 132 | MP0002398_abnormal_bone_marrow | 0.73173686 |
| 133 | MP0009278_abnormal_bone_marrow | 0.73104748 |
| 134 | MP0010329_abnormal_lipoprotein_level | 0.73100193 |
| 135 | MP0005174_abnormal_tail_pigmentation | 0.72914643 |
| 136 | MP0009765_abnormal_xenobiotic_induced | 0.72683154 |
| 137 | MP0005621_abnormal_cell_physiology | 0.71883626 |
| 138 | MP0000858_altered_metastatic_potential | 0.71671134 |
| 139 | MP0000249_abnormal_blood_vessel | 0.71395763 |
| 140 | MP0002019_abnormal_tumor_incidence | 0.71291974 |
| 141 | MP0001502_abnormal_circadian_rhythm | 0.70456483 |
| 142 | MP0000609_abnormal_liver_physiology | 0.70201505 |
| 143 | MP0004147_increased_porphyrin_level | 0.69955691 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.69481867 |
| 145 | MP0002132_abnormal_respiratory_system | 0.66212064 |
| 146 | MP0008961_abnormal_basal_metabolism | 0.65991044 |
| 147 | MP0003935_abnormal_craniofacial_develop | 0.65981231 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65440012 |
| 149 | MP0002092_abnormal_eye_morphology | 0.64090192 |
| 150 | MP0005384_cellular_phenotype | 0.64000727 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.63888547 |
| 152 | MP0003448_altered_tumor_morphology | 0.63704466 |
| 153 | MP0005310_abnormal_salivary_gland | 0.63697322 |
| 154 | MP0002752_abnormal_somatic_nervous | 0.63021488 |
| 155 | MP0005164_abnormal_response_to | 0.62916691 |
| 156 | MP0009780_abnormal_chondrocyte_physiolo | 0.62805016 |
| 157 | MP0005083_abnormal_biliary_tract | 0.62734972 |
| 158 | MP0002127_abnormal_cardiovascular_syste | 0.61963242 |
| 159 | MP0001666_abnormal_nutrient_absorption | 0.61433514 |
| 160 | MP0001764_abnormal_homeostasis | 0.61091129 |
| 161 | MP0000490_abnormal_crypts_of | 0.59744616 |
| 162 | MP0005257_abnormal_intraocular_pressure | 0.59129085 |
| 163 | MP0005171_absent_coat_pigmentation | 0.57612310 |
| 164 | MP0008932_abnormal_embryonic_tissue | 0.57256269 |
| 165 | MP0001986_abnormal_taste_sensitivity | 0.56565173 |
| 166 | MP0008004_abnormal_stomach_pH | 0.56430819 |
| 167 | MP0003300_gastrointestinal_ulcer | 0.55396718 |
| 168 | MP0005220_abnormal_exocrine_pancreas | 0.55307223 |
| 169 | MP0001835_abnormal_antigen_presentation | 0.54877108 |
| 170 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54724112 |
| 171 | MP0000432_abnormal_head_morphology | 0.52952515 |
| 172 | MP0009115_abnormal_fat_cell | 0.52831312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.96780096 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 6.34835445 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.86882384 |
| 4 | Dyschromatopsia (HP:0007641) | 4.80763174 |
| 5 | T lymphocytopenia (HP:0005403) | 4.69016747 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.64660551 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.53292736 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.49162975 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.37606378 |
| 10 | Central scotoma (HP:0000603) | 4.23223690 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.18255925 |
| 12 | Scotoma (HP:0000575) | 4.17471896 |
| 13 | Chorioretinal atrophy (HP:0000533) | 4.13427199 |
| 14 | Pendular nystagmus (HP:0012043) | 3.98776631 |
| 15 | Pigmentary retinal degeneration (HP:0001146) | 3.96034420 |
| 16 | Attenuation of retinal blood vessels (HP:0007843) | 3.91829394 |
| 17 | Cone-rod dystrophy (HP:0000548) | 3.91122559 |
| 18 | Abnormality of macular pigmentation (HP:0008002) | 3.89641667 |
| 19 | Stomatitis (HP:0010280) | 3.89529935 |
| 20 | Decreased central vision (HP:0007663) | 3.85600459 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85398249 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85398249 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 3.82663853 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.75761891 |
| 25 | Neoplasm of the oral cavity (HP:0100649) | 3.71916185 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61830528 |
| 27 | Type II diabetes mellitus (HP:0005978) | 3.55440166 |
| 28 | Photophobia (HP:0000613) | 3.45155187 |
| 29 | Recurrent skin infections (HP:0001581) | 3.44894126 |
| 30 | Ependymoma (HP:0002888) | 3.42830717 |
| 31 | Myositis (HP:0100614) | 3.42753271 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.41591444 |
| 33 | Optic neuritis (HP:0100653) | 3.41591444 |
| 34 | Colitis (HP:0002583) | 3.38964929 |
| 35 | Gingival bleeding (HP:0000225) | 3.36661169 |
| 36 | Abnormality of T cells (HP:0002843) | 3.36094510 |
| 37 | Meningitis (HP:0001287) | 3.31834958 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.30131716 |
| 39 | IgM deficiency (HP:0002850) | 3.27511692 |
| 40 | Recurrent viral infections (HP:0004429) | 3.25256299 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 3.21508526 |
| 42 | Volvulus (HP:0002580) | 3.20442507 |
| 43 | Recurrent bronchitis (HP:0002837) | 3.17392834 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 3.17237478 |
| 45 | Macular degeneration (HP:0000608) | 3.15379185 |
| 46 | Vasculitis (HP:0002633) | 3.15320093 |
| 47 | Inflammation of the large intestine (HP:0002037) | 3.13400106 |
| 48 | Abolished electroretinogram (ERG) (HP:0000550) | 3.08673883 |
| 49 | Orchitis (HP:0100796) | 3.05530404 |
| 50 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.05243402 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.99241351 |
| 52 | Posterior subcapsular cataract (HP:0007787) | 2.98824492 |
| 53 | Agammaglobulinemia (HP:0004432) | 2.98490414 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.93792503 |
| 55 | Chronic diarrhea (HP:0002028) | 2.92871279 |
| 56 | IgG deficiency (HP:0004315) | 2.92263397 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.91302815 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.90204505 |
| 59 | IgA deficiency (HP:0002720) | 2.83339693 |
| 60 | Pustule (HP:0200039) | 2.81535277 |
| 61 | Abnormality of the astrocytes (HP:0100707) | 2.81396314 |
| 62 | Astrocytoma (HP:0009592) | 2.81396314 |
| 63 | Agnosia (HP:0010524) | 2.80137178 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.75980313 |
| 65 | Gingivitis (HP:0000230) | 2.73634342 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.70609737 |
| 67 | Hypoplasia of the thymus (HP:0000778) | 2.70435203 |
| 68 | Severe combined immunodeficiency (HP:0004430) | 2.70032529 |
| 69 | Lymphopenia (HP:0001888) | 2.66507764 |
| 70 | Encephalitis (HP:0002383) | 2.65810462 |
| 71 | Stomach cancer (HP:0012126) | 2.65663385 |
| 72 | Vitreoretinal degeneration (HP:0000655) | 2.60496216 |
| 73 | Medulloblastoma (HP:0002885) | 2.59559455 |
| 74 | Thyroiditis (HP:0100646) | 2.58165679 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 2.57678918 |
| 76 | Epistaxis (HP:0000421) | 2.55230597 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.54228905 |
| 78 | Leukocytosis (HP:0001974) | 2.52796066 |
| 79 | Osteomyelitis (HP:0002754) | 2.52639974 |
| 80 | Glioma (HP:0009733) | 2.52309689 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.51989287 |
| 82 | Abnormality of the labia minora (HP:0012880) | 2.51986423 |
| 83 | Hemoptysis (HP:0002105) | 2.51758005 |
| 84 | Constricted visual fields (HP:0001133) | 2.50181729 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48533211 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.46765971 |
| 87 | Abnormality of B cell number (HP:0010975) | 2.40187034 |
| 88 | Eosinophilia (HP:0001880) | 2.35634257 |
| 89 | Granulocytopenia (HP:0001913) | 2.33639799 |
| 90 | Arterial thrombosis (HP:0004420) | 2.33218415 |
| 91 | Cellulitis (HP:0100658) | 2.31742236 |
| 92 | Viral hepatitis (HP:0006562) | 2.31605460 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 2.30061956 |
| 94 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.28571644 |
| 95 | Retinitis pigmentosa (HP:0000510) | 2.28213446 |
| 96 | Chest pain (HP:0100749) | 2.27305833 |
| 97 | Slow saccadic eye movements (HP:0000514) | 2.27008988 |
| 98 | Pulmonary embolism (HP:0002204) | 2.25472788 |
| 99 | Recurrent sinusitis (HP:0011108) | 2.23508704 |
| 100 | Prolonged bleeding time (HP:0003010) | 2.23172090 |
| 101 | Joint swelling (HP:0001386) | 2.22978926 |
| 102 | Acute myeloid leukemia (HP:0004808) | 2.22382142 |
| 103 | Amaurosis fugax (HP:0100576) | 2.22274287 |
| 104 | Hematochezia (HP:0002573) | 2.21682280 |
| 105 | Poikilocytosis (HP:0004447) | 2.20983531 |
| 106 | Gastrointestinal stroma tumor (HP:0100723) | 2.19437817 |
| 107 | Increased IgE level (HP:0003212) | 2.19054458 |
| 108 | Abnormality of the prostate (HP:0008775) | 2.16531337 |
| 109 | Acute hepatic failure (HP:0006554) | 2.15189126 |
| 110 | Choroideremia (HP:0001139) | 2.14317397 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.13372620 |
| 112 | Urticaria (HP:0001025) | 2.11877502 |
| 113 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.10859087 |
| 114 | Hypoplasia of the fovea (HP:0007750) | 2.10859087 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 2.09177384 |
| 116 | Severe visual impairment (HP:0001141) | 2.08805613 |
| 117 | Birth length less than 3rd percentile (HP:0003561) | 2.08791208 |
| 118 | Chromsome breakage (HP:0040012) | 2.08537649 |
| 119 | Intestinal atresia (HP:0011100) | 2.06949301 |
| 120 | Papilloma (HP:0012740) | 2.04567340 |
| 121 | Verrucae (HP:0200043) | 2.04567340 |
| 122 | Abnormality of the fingertips (HP:0001211) | 2.03507324 |
| 123 | Keratoconus (HP:0000563) | 2.02939275 |
| 124 | Increased corneal curvature (HP:0100692) | 2.02939275 |
| 125 | Acanthocytosis (HP:0001927) | 2.02932464 |
| 126 | Combined immunodeficiency (HP:0005387) | 2.02332102 |
| 127 | B lymphocytopenia (HP:0010976) | 2.00889756 |
| 128 | Prominent nose (HP:0000448) | 1.99687514 |
| 129 | Subacute progressive viral hepatitis (HP:0006572) | 1.98812661 |
| 130 | Anal stenosis (HP:0002025) | 1.97786072 |
| 131 | Ectopic kidney (HP:0000086) | 1.97205739 |
| 132 | Bronchitis (HP:0012387) | 1.95040851 |
| 133 | Progressive visual loss (HP:0000529) | 1.94165234 |
| 134 | Supernumerary spleens (HP:0009799) | 1.93955808 |
| 135 | Colon cancer (HP:0003003) | 1.90523925 |
| 136 | Thrombophlebitis (HP:0004418) | 1.90023685 |
| 137 | Polyneuropathy (HP:0001271) | 1.89894010 |
| 138 | Deep philtrum (HP:0002002) | 1.89198030 |
| 139 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88910839 |
| 140 | Rhabdomyosarcoma (HP:0002859) | 1.88566930 |
| 141 | Hypochromic microcytic anemia (HP:0004840) | 1.88393928 |
| 142 | Aplastic anemia (HP:0001915) | 1.87468865 |
| 143 | Scanning speech (HP:0002168) | 1.87300866 |
| 144 | Hypochromic anemia (HP:0001931) | 1.87006416 |
| 145 | Gangrene (HP:0100758) | 1.86966693 |
| 146 | Obstructive lung disease (HP:0006536) | 1.86418898 |
| 147 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86418898 |
| 148 | Hypoplastic labia majora (HP:0000059) | 1.82042877 |
| 149 | Hepatitis (HP:0012115) | 1.81929803 |
| 150 | Myelodysplasia (HP:0002863) | 1.81282781 |
| 151 | Papillary thyroid carcinoma (HP:0002895) | 1.80424676 |
| 152 | Fair hair (HP:0002286) | 1.78315088 |
| 153 | Subcapsular cataract (HP:0000523) | 1.78067505 |
| 154 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.78054636 |
| 155 | Gastrointestinal carcinoma (HP:0002672) | 1.78054636 |
| 156 | Keratitis (HP:0000491) | 1.77595429 |
| 157 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.75017125 |
| 158 | Urethral obstruction (HP:0000796) | 1.72995700 |
| 159 | Acute lymphatic leukemia (HP:0006721) | 1.72268381 |
| 160 | Abnormality of the fovea (HP:0000493) | 1.70673114 |
| 161 | Esophageal atresia (HP:0002032) | 1.69584529 |
| 162 | Truncal obesity (HP:0001956) | 1.68556676 |
| 163 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.68040794 |
| 164 | Gastrointestinal atresia (HP:0002589) | 1.66478395 |
| 165 | Wide nasal bridge (HP:0000431) | 1.66335619 |
| 166 | Neoplasm of the adrenal cortex (HP:0100641) | 1.65708166 |
| 167 | Abnormality of the salivary glands (HP:0010286) | 1.64312892 |
| 168 | Abnormality of DNA repair (HP:0003254) | 1.62667694 |
| 169 | Biliary tract neoplasm (HP:0100574) | 1.58650124 |
| 170 | Abnormality of the labia majora (HP:0012881) | 1.58342432 |
| 171 | Sloping forehead (HP:0000340) | 1.58069187 |
| 172 | Abnormality of the hepatic vasculature (HP:0006707) | 1.58056449 |
| 173 | Portal hypertension (HP:0001409) | 1.56563152 |
| 174 | Spinal muscular atrophy (HP:0007269) | 1.55307049 |
| 175 | Congenital sensorineural hearing impairment (HP:0008527) | 1.53645536 |
| 176 | Freckling (HP:0001480) | 1.53388222 |
| 177 | Abnormality of chromosome stability (HP:0003220) | 1.52873096 |
| 178 | Abnormal biliary tract morphology (HP:0012440) | 1.49310281 |
| 179 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.48856556 |
| 180 | Homocystinuria (HP:0002156) | 1.48245828 |
| 181 | Abnormality of homocysteine metabolism (HP:0010919) | 1.48245828 |
| 182 | Neoplasm of striated muscle (HP:0009728) | 1.48056115 |
| 183 | Premature graying of hair (HP:0002216) | 1.47443702 |
| 184 | Pancreatic fibrosis (HP:0100732) | 1.43916142 |
| 185 | Septo-optic dysplasia (HP:0100842) | 1.43733312 |
| 186 | Genetic anticipation (HP:0003743) | 1.42317431 |
| 187 | Hypoplasia of the maxilla (HP:0000327) | 1.42255604 |
| 188 | Lip pit (HP:0100267) | 1.41940530 |
| 189 | Retinal atrophy (HP:0001105) | 1.41892105 |
| 190 | Deviation of the thumb (HP:0009603) | 1.41553803 |
| 191 | Basal cell carcinoma (HP:0002671) | 1.41088915 |
| 192 | Hypoplastic ischia (HP:0003175) | 1.40229386 |
| 193 | Lymphoma (HP:0002665) | 1.38730692 |
| 194 | Dysmetric saccades (HP:0000641) | 1.38401949 |
| 195 | Bone marrow hypocellularity (HP:0005528) | 1.37708384 |
| 196 | Trigonocephaly (HP:0000243) | 1.37697971 |
| 197 | Proximal placement of thumb (HP:0009623) | 1.37420098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 4.00630803 |
| 2 | AKT3 | 3.68436966 |
| 3 | GRK1 | 3.35973178 |
| 4 | RIPK4 | 3.29905159 |
| 5 | BLK | 3.18626772 |
| 6 | BRD4 | 2.59042356 |
| 7 | MKNK2 | 2.50362595 |
| 8 | FES | 2.29462331 |
| 9 | IRAK4 | 2.16752038 |
| 10 | CDC7 | 2.13308947 |
| 11 | BMPR2 | 2.13215489 |
| 12 | BUB1 | 2.09989855 |
| 13 | TAOK3 | 2.09549028 |
| 14 | ZAK | 2.09463635 |
| 15 | IKBKE | 2.03733698 |
| 16 | EPHA2 | 2.01522187 |
| 17 | MAP3K13 | 1.95645009 |
| 18 | BTK | 1.95315260 |
| 19 | PRPF4B | 1.92406268 |
| 20 | PIK3CG | 1.90097347 |
| 21 | GRK6 | 1.89950035 |
| 22 | ACVR1B | 1.89946446 |
| 23 | FLT3 | 1.87906712 |
| 24 | SYK | 1.86896815 |
| 25 | TSSK6 | 1.79478734 |
| 26 | INSRR | 1.78819065 |
| 27 | TTK | 1.72973697 |
| 28 | ATR | 1.66433315 |
| 29 | MKNK1 | 1.66132209 |
| 30 | NEK2 | 1.65235068 |
| 31 | TXK | 1.62661133 |
| 32 | CAMKK2 | 1.62213416 |
| 33 | PASK | 1.61903858 |
| 34 | NEK1 | 1.58960466 |
| 35 | WEE1 | 1.57728387 |
| 36 | PLK3 | 1.46890616 |
| 37 | CHEK2 | 1.42373475 |
| 38 | HCK | 1.41543028 |
| 39 | FGR | 1.39986305 |
| 40 | CHEK1 | 1.39666733 |
| 41 | RPS6KA4 | 1.39331574 |
| 42 | ZAP70 | 1.38863757 |
| 43 | CSF1R | 1.37217728 |
| 44 | LYN | 1.35402456 |
| 45 | LCK | 1.31503565 |
| 46 | ATM | 1.31490663 |
| 47 | NLK | 1.26180326 |
| 48 | RPS6KB2 | 1.25204746 |
| 49 | LATS1 | 1.24902682 |
| 50 | CAMK1D | 1.22903425 |
| 51 | BRSK2 | 1.21825910 |
| 52 | ERBB3 | 1.21064319 |
| 53 | SIK3 | 1.20882390 |
| 54 | FRK | 1.16013955 |
| 55 | IKBKB | 1.15030742 |
| 56 | SGK2 | 1.14435540 |
| 57 | JAK2 | 1.12088670 |
| 58 | MAPK11 | 1.10250037 |
| 59 | FGFR4 | 1.09211197 |
| 60 | JAK3 | 1.04966626 |
| 61 | SRPK1 | 1.00455753 |
| 62 | HIPK2 | 1.00095755 |
| 63 | TNK2 | 0.99717318 |
| 64 | VRK1 | 0.97954896 |
| 65 | PLK1 | 0.97110319 |
| 66 | CDK7 | 0.97097650 |
| 67 | AURKB | 0.95783146 |
| 68 | PDK1 | 0.94203729 |
| 69 | TBK1 | 0.94178736 |
| 70 | MARK3 | 0.93864308 |
| 71 | STK24 | 0.93293864 |
| 72 | YES1 | 0.91515571 |
| 73 | TEC | 0.91297311 |
| 74 | TGFBR1 | 0.89606587 |
| 75 | CSNK1D | 0.89525225 |
| 76 | EIF2AK3 | 0.89254548 |
| 77 | CDK2 | 0.88845963 |
| 78 | MARK2 | 0.88616024 |
| 79 | TIE1 | 0.88198603 |
| 80 | DYRK3 | 0.87770780 |
| 81 | MAP2K3 | 0.87320171 |
| 82 | PRKCQ | 0.86912055 |
| 83 | MELK | 0.86048354 |
| 84 | SGK3 | 0.85032263 |
| 85 | CCNB1 | 0.84901014 |
| 86 | STK10 | 0.84473447 |
| 87 | MAP4K1 | 0.83655107 |
| 88 | PDGFRB | 0.82577952 |
| 89 | CDK6 | 0.82488320 |
| 90 | CDK1 | 0.79975495 |
| 91 | CDK9 | 0.78818535 |
| 92 | FGFR3 | 0.78362214 |
| 93 | NEK6 | 0.78152081 |
| 94 | CAMKK1 | 0.75486621 |
| 95 | MAPK14 | 0.75247317 |
| 96 | MAP3K7 | 0.74980047 |
| 97 | CHUK | 0.72108942 |
| 98 | MAP3K2 | 0.71867640 |
| 99 | PNCK | 0.71247808 |
| 100 | CDK3 | 0.69839694 |
| 101 | PTK2B | 0.68270779 |
| 102 | AKT1 | 0.67245755 |
| 103 | STK4 | 0.67007478 |
| 104 | GSK3B | 0.66450496 |
| 105 | MTOR | 0.66437215 |
| 106 | MAP3K1 | 0.65936494 |
| 107 | PIM1 | 0.64045299 |
| 108 | RPS6KB1 | 0.63540061 |
| 109 | STK3 | 0.63285257 |
| 110 | ALK | 0.63226900 |
| 111 | PRKDC | 0.62907084 |
| 112 | SGK223 | 0.62091334 |
| 113 | SGK494 | 0.62091334 |
| 114 | CSK | 0.60397548 |
| 115 | STK38 | 0.59156524 |
| 116 | TRPM7 | 0.58593164 |
| 117 | FGFR1 | 0.58570704 |
| 118 | EGFR | 0.57862535 |
| 119 | JAK1 | 0.57622534 |
| 120 | CAMK4 | 0.57083787 |
| 121 | RPS6KA5 | 0.56320352 |
| 122 | MAP3K14 | 0.55519250 |
| 123 | RET | 0.55285522 |
| 124 | MAPK10 | 0.54814741 |
| 125 | MAP3K10 | 0.54455072 |
| 126 | MAPK12 | 0.52269907 |
| 127 | MAP3K6 | 0.51743457 |
| 128 | PRKAA2 | 0.51386016 |
| 129 | EPHA3 | 0.51252891 |
| 130 | MAPK7 | 0.50635130 |
| 131 | PINK1 | 0.50548429 |
| 132 | NEK9 | 0.50414968 |
| 133 | NUAK1 | 0.50252194 |
| 134 | KSR2 | 0.49335314 |
| 135 | FYN | 0.48926573 |
| 136 | CDK4 | 0.48253477 |
| 137 | MST4 | 0.48213052 |
| 138 | CAMK1G | 0.48210340 |
| 139 | MAP3K5 | 0.48127140 |
| 140 | CSNK1E | 0.48109831 |
| 141 | MAPK1 | 0.47634725 |
| 142 | SCYL2 | 0.46824726 |
| 143 | SGK1 | 0.46635420 |
| 144 | TLK1 | 0.45878681 |
| 145 | MAP2K2 | 0.45854082 |
| 146 | PIK3CA | 0.45193306 |
| 147 | WNK1 | 0.45036234 |
| 148 | ABL1 | 0.42032561 |
| 149 | PKN2 | 0.41327208 |
| 150 | MATK | 0.41205695 |
| 151 | PDPK1 | 0.40858150 |
| 152 | KIT | 0.39908955 |
| 153 | ITK | 0.39710074 |
| 154 | TYK2 | 0.39483450 |
| 155 | CDC42BPA | 0.38843235 |
| 156 | SIK2 | 0.38172507 |
| 157 | PRKAA1 | 0.36840789 |
| 158 | EIF2AK2 | 0.36639551 |
| 159 | BMX | 0.36181761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 7.06827851 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.54111960 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.52017192 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.39443748 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.32785979 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.30905101 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.20518119 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.84854167 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 1.82447849 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75939260 |
| 11 | RNA degradation_Homo sapiens_hsa03018 | 1.66788321 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.65419113 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64827245 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.63933868 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.63577679 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 1.63114710 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59707247 |
| 18 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.58564122 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.57582005 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.46552874 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.45848039 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.40469724 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39613767 |
| 24 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.33615790 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32966281 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32483609 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32226709 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.30951572 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30876402 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27301169 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.26628618 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24512180 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22223205 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21296410 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.20237381 |
| 36 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.17568312 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16740450 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14421370 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.13045221 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12182634 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.12099507 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12045780 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01236085 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00027018 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98974746 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96680135 |
| 47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.96170756 |
| 48 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95850456 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93361034 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92450017 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92395076 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91620993 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.90701940 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89620842 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89236713 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87900440 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.87176307 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87127538 |
| 59 | Measles_Homo sapiens_hsa05162 | 0.85953939 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85219460 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85076587 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81454098 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81306826 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78936208 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78449100 |
| 66 | Alcoholism_Homo sapiens_hsa05034 | 0.77316706 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76342245 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.74367969 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73481170 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73346294 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69926043 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68634249 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68466703 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.67808011 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67278696 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.67264891 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66045481 |
| 78 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65922089 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64885399 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64480886 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63965139 |
| 82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63617869 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.63220443 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63179188 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62262420 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62188373 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.60968920 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59639319 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59345753 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.58214079 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58007244 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57506065 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.56449133 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56203698 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56146346 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55693536 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55654367 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55554554 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55072748 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.53925453 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53313646 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51170998 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50788369 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50435925 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.50314231 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50168428 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.49934558 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49810434 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49358671 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.49060721 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48718854 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48596108 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.48384839 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47628784 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46486800 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46419759 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46113160 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45517027 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45269912 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44709786 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44157616 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43953361 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43618494 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42899645 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41969301 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41963776 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.41800479 |
| 128 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41667860 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41657793 |
| 130 | Morphine addiction_Homo sapiens_hsa05032 | 0.41001661 |
| 131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40982582 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40860868 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39551248 |
| 134 | Allograft rejection_Homo sapiens_hsa05330 | 0.37938839 |
| 135 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37838670 |
| 136 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36995938 |
| 137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36383876 |
| 138 | Melanoma_Homo sapiens_hsa05218 | 0.36147405 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36018310 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35362371 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35128072 |
| 142 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34869908 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34730270 |
| 144 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34248376 |
| 145 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33876385 |
| 146 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33286775 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.32601656 |
| 148 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29217070 |
| 149 | Glioma_Homo sapiens_hsa05214 | 0.28222896 |
| 150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27384469 |
| 151 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27360856 |

